Bank of America’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $827K | Sell |
713,315
-416,777
| -37% | -$483K | ﹤0.01% | 4552 |
|
|
2025
Q1 | $1.8M | Buy |
1,130,092
+914,093
| +423% | +$1.45M | ﹤0.01% | 3995 |
|
|
2024
Q4 | $654K | Sell |
215,999
-559,537
| -72% | -$1.7M | ﹤0.01% | 4528 |
|
|
2024
Q3 | $2.85M | Buy |
775,536
+267,303
| +53% | +$984K | ﹤0.01% | 3611 |
|
|
2024
Q2 | $2.08M | Buy |
508,233
+32,277
| +7% | +$132K | ﹤0.01% | 3762 |
|
|
2024
Q1 | $7.5M | Sell |
475,956
-242,687
| -34% | -$3.82M | ﹤0.01% | 2770 |
|
|
2023
Q4 | $10.9M | Buy |
718,643
+485,680
| +208% | +$7.36M | ﹤0.01% | 2338 |
|
|
2023
Q3 | $4.67M | Sell |
232,963
-32,521
| -12% | -$652K | ﹤0.01% | 2904 |
|
|
2023
Q2 | $7.49M | Sell |
265,484
-34,806
| -12% | -$982K | ﹤0.01% | 2543 |
|
|
2023
Q1 | $5.16M | Buy |
300,290
+59,950
| +25% | +$1.03M | ﹤0.01% | 2999 |
|
|
2022
Q4 | $4.84M | Buy |
240,340
+118,205
| +97% | +$2.38M | ﹤0.01% | 2922 |
|
|
2022
Q3 | $2.65M | Sell |
122,135
-187,332
| -61% | -$4.06M | ﹤0.01% | 3427 |
|
|
2022
Q2 | $8.7M | Buy |
309,467
+25,219
| +9% | +$709K | ﹤0.01% | 2431 |
|
|
2022
Q1 | $13.1M | Buy |
284,248
+86,859
| +44% | +$4.01M | ﹤0.01% | 2254 |
|
|
2021
Q4 | $16.6M | Buy |
197,389
+113,038
| +134% | +$9.5M | ﹤0.01% | 2076 |
|
|
2021
Q3 | $5.62M | Buy |
84,351
+2,524
| +3% | +$168K | ﹤0.01% | 2965 |
|
|
2021
Q2 | $4.35M | Sell |
81,827
-8,715
| -10% | -$464K | ﹤0.01% | 3146 |
|
|
2021
Q1 | $3.93M | Buy |
90,542
+42,478
| +88% | +$1.84M | ﹤0.01% | 3207 |
|
|
2020
Q4 | $2.5M | Buy |
48,064
+18,132
| +61% | +$942K | ﹤0.01% | 3233 |
|
|
2020
Q3 | $979K | Buy |
29,932
+12,993
| +77% | +$425K | ﹤0.01% | 3716 |
|
|
2020
Q2 | $814K | Buy |
+16,939
| New | +$814K | ﹤0.01% | 3797 |
|